Literature DB >> 18716017

Epstein-Barr virus and Burkitt lymphoma.

G Brady1, G J Macarthur, P J Farrell.   

Abstract

Burkitt lymphoma (BL) is an aggressive B-cell malignancy with endemic, sporadic and immunodeficiency-associated variants. It has been known for many years that the fundamental transforming event in BL is the translocation of the MYC gene, and the events that bring about this translocation and those that allow cells to survive with the constitutive expression of MYC have been the subject of intense investigation. Epstein-Barr virus (EBV) infection, malaria, immunodeficiency and spontaneous, somatic mutation can all contribute to the origin and maintenance of this cancer and their mechanisms are the subject of this review.

Entities:  

Mesh：

Year:  2008        PMID： 18716017     DOI： 10.1136/jcp.2007.047977

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  26 in total

Review 1.  Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.

Authors:  Catarina Dias; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2011-06       Impact factor: 20.543

2.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

3.  Malignancy in systemic lupus erythematosus: what have we learned?

Authors:  Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-08       Impact factor: 4.098

Review 4.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

5.  DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma.

Authors:  S Lee; N Syed; J Taylor; P Smith; B Griffin; M Baens; M Bai; K Bourantas; J Stebbing; K Naresh; M Nelson; M Tuthill; M Bower; E Hatzimichael; T Crook
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

6.  Burkitt lymphoma: pathogenesis and immune evasion.

Authors:  Jason M God; Azizul Haque
Journal:  J Oncol       Date:  2010-10-05       Impact factor: 4.375

7.  Epstein-barr virus, the immune system, and associated diseases.

Authors:  Mei-Ru Chen
Journal:  Front Microbiol       Date:  2011-01-26       Impact factor: 5.640

8.  Evaluation of Epstein-Barr virus latent membrane protein 2 specific T-cell receptors driven by T-cell specific promoters using lentiviral vector.

Authors:  Dongchang Yang; Qing Shao; Hua Sun; Xiaoxin Mu; Yun Gao; Runqiu Jiang; Jiajie Hou; Kun Yao; Yun Chen; Beicheng Sun
Journal:  Clin Dev Immunol       Date:  2011-09-28

9.  Construction and identification of recombinant lentiviral vector containing HIV-1 Tat gene and its expression in 293T cells.

Authors:  Bingbing Wei; Ninghan Feng; Feng Zhou; Chun Lu; Jiantang Su; Lixin Hua
Journal:  J Biomed Res       Date:  2010-01

10.  Burkitt's Lymphoma in a Pregnant Woman: Case Report and Review of the Literature.

Authors:  Carlos Zagalo; Francesca Pierdomenico; José Cabeçadas; Pedro David Santos
Journal:  Case Rep Oncol Med       Date:  2013-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.